Literature DB >> 8753114

[Lymphangiomyomatosis with chylous ascites treatment successfully by peritoneo-venous shunting].

M Kimura1, T Morikawa, K Takeuchi, H Furuie, M Fukimura, R Mikami, Y Kakuta, S Kawamura, Y Tashiro.   

Abstract

A 49-year-old woman was admitted to our hospital because of coughing and dyspnea. A chest roentogenogram showed emphysematous changes and a diffuse reticular shadow. A high-resolution CT scan of the chest showed many small cysts throughout the lungs. Lymphangiomyomatosis was diagnosed after examination of a specimen obtained by transbronchial biopsy. Abdominal distention due to chylous ascites developed during the hospital stay despite anti-estrogen therapy. Because the ascites was resistant to conservative therapy, we decided to begin peritoneo-venous shunting with a Denver Shunt system. After the operation, the abdominal distention was controlled for 1 year and 11 months, at which time the patient died of respiratory and heart failure with pneumonia. At autopsy, the shunt was patent and functional although about 900 ml of serous ascites fluid was present. An adenocarcinoma was found in the upper lobe of the right lung, but it may not have been related to the lymphangiomyomatosis. Peritoneovenous shunting with a Denver Shunt can be used to treat chylous ascites due to lymphangiomyomatosis when conservative therapy is insufficient.

Entities:  

Mesh:

Year:  1996        PMID: 8753114

Source DB:  PubMed          Journal:  Nihon Kyobu Shikkan Gakkai Zasshi        ISSN: 0301-1542


  3 in total

1.  Peritoneovenous shunt after failure of octreotide treatment for chylous ascites in lymphangioleiomyomatosis.

Authors:  Laurent Lefrou; Louis d'Alteroche; Yahia Harchaoui; Dominique Franco; Etienne Henry Metman
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

2.  Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going.

Authors:  Angelo M Taveira-Dasilva; Wendy K Steagall; Joel Moss
Journal:  F1000 Med Rep       Date:  2009-12-09

Review 3.  Management of lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  F1000Prime Rep       Date:  2014-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.